Rates of Treatment Discontinuation Due to Adverse Events for Echinocandins

Lignende værker

• TO DISCONTINUE OR TO WAIT?: INDICATIONS FOR DISCONTINUATION OF ANTI-TUBERCULOSIS DRUGS DUE TO ADVERSE EVENTS
  af: D. A. Ivаnovа, et al.
  Udgivet: (2018-03-01)
• Serious Adverse Events During Ruxolitinib Treatment Discontinuation in Patients With Myelofibrosis
  af: Tefferi, Ayalew, et al.
  Udgivet: (2011)
• Treatment Outcomes after Discontinuation of Ethambutol due to Adverse Events in Mycobacterium avium Complex Lung Disease
  af: Kwon, Yong Shik, et al.
  Udgivet: (2020)
• Zonisamide discontinuation due to psychiatric and cognitive adverse events: A case-control study
  af: White, J.R., et al.
  Udgivet: (2010)
• FEMALE SEX AND DISCONTINUATION OF ISONIAZID DUE TO ADVERSE EFFECTS DURING THE TREATMENT OF LATENT TUBERCULOSIS
  af: Pettit, April C., et al.
  Udgivet: (2013)